Chevy Chase Trust Holdings LLC Has $183.22 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Chevy Chase Trust Holdings LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 369,930 shares of the medical equipment provider’s stock after selling 18,514 shares during the quarter. Intuitive Surgical makes up approximately 0.6% of Chevy Chase Trust Holdings LLC’s portfolio, making the stock its 27th biggest position. Chevy Chase Trust Holdings LLC owned 0.10% of Intuitive Surgical worth $183,215,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Atala Financial Inc acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $25,000. Hurley Capital LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $28,000. Parvin Asset Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $28,000. Finally, Global Financial Private Client LLC raised its stake in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 38 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.1%

Intuitive Surgical stock opened at $515.09 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The business’s 50 day simple moving average is $528.53 and its 200 day simple moving average is $537.06. The company has a market cap of $184.62 billion, a price-to-earnings ratio of 75.53, a PEG ratio of 5.40 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the business posted $1.50 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president now owns 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of the stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock worth $2,611,577 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ISRG. Robert W. Baird dropped their price target on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Barclays decreased their price objective on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a report on Wednesday, April 23rd. Finally, Royal Bank Of Canada decreased their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.